Single-Cell Encapsulated Bacteria

Non-Exclusively Licensed

Methods of encapsulating microorganisms, or components thereof, for targeted enteric delivery to an animal host have been developed. In particular, the encapsulation provides a prolonged survival, extended retention and a pH-sensitive release of the encapsulated microorganisms or antigenic components thereof at targeted sites within the gastrointestinal tract. The formulations are useful for diagnostic, therapeutic and prophylactic purposes and can alter a host's microbial composition associated with a condition or a disease state.

Researchers

Robert Langer / Aaron Anselmo / Ana Jaklenec

Departments: Office of the Institute Professors, David H Koch Institute for Integrative Cancer Res
Technology Areas: Biotechnology: Synthetic Biology / Chemicals & Materials: Composites, Polymers / Therapeutics: Cell Based Therapy
Impact Areas: Healthy Living

  • ph-responsive mucoadhesive polymeric encapsulated microorganisms
    United States of America | Granted | 10,548,844

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies